R&D Center
Independent innovation, scientific and technological innovation, cutting-edge scientificresearch technology and application innovation design in international industry, PDRN/PNefficacy type formula development and comprehensive expansion, focusing on leading thetechnological innovation of marine nucleic acid type regenerative medicine in China
Zhengyu Base
Production license for national Class ll medical device, has taken the lead in completing thedesign and application of PDRN/PN Class lll medical devices. has achieved the domesticindependent mass production of PDRN multi-category medical devices and international source supply.
：+8618866656567
：HENGYUBIOPH@hypdrn.com